Metabolism and Sleep Apnea Treatment
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-70
SponsorUniversity of Miami
About this trial
The purpose of this research study is to see if obstructive sleep apnea (OSA) is associated with abnormalities in fat metabolism. Through this research study, the Investigator will evaluate how fat is metabolized in people with and without sleep apnea, what substances the fat tissue releases, and how these substances might change the way the body uses energy and sugar.
Eligibility criteria
Qualifiers
Age between 18-70 years
Ability to provide consent
Disqualifiers
Body Mass Index (BMI) > 40 kg/m2
Prevalent myocardial infarction, coronary revascularization, heart failure, and stroke
Type 1 or Type 2 diabetes mellitus
Current or prior use of PAP or oral appliance therapy for OSA
Trial design
Treatments tested in this trial
- PAP Therapy
- Lifestyle Counseling Intervention
Treatment groups
100 Participants
are divided into 3 treatment groupsSponsors and collaborators
University of Miami
Lead sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Collaborator
Source ClinicalTrials.gov